The Scotts Miracle-Gro Company logo
The Scotts Miracle-Gro Company SMG
$ 57.45 3.7%

Annual report 2025
added 11-25-2025

report update icon

The Scotts Miracle-Gro Company Financial Ratios 2011-2025 | SMG

Annual Financial Ratios The Scotts Miracle-Gro Company

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

22.0 -126.1 -8.3 -6.8 17.3 27.9 11.9 59.9 26.9 17.1 25.3 21.7 22.4 24.0 19.3

P/S

0.9 1.2 0.9 0.8 1.8 2.6 1.7 1.4 2.2 1.9 1.3 1.3 1.3 0.9 1.1

EPS

2.5 -0.6 -6.8 -7.9 9.2 7.0 8.3 1.1 3.7 5.2 2.6 2.7 2.6 1.8 2.6

EV (Enterprise Value)

6.26 B 7.59 B 6.79 B 7.04 B 12.4 B 13.5 B 7.76 B 6.48 B 7.83 B 7.44 B 5.89 B 5.01 B 4.71 B 3.9 B 4.59 B

EBITDA per Share

7.31 4.82 -1.91 -5.92 14.7 12.2 8.11 6.42 7.59 6.96 7.13 6.02 6.28 5.12 5.64

EV/EBITDA

15.2 16.0 15.8 16.1 15.9 15.7 11.8 11.6 10.5 10.3 10.7

PEG

-0.23 1.29 0.37 0.58 0.96 2.05 0.02 -0.86 -0.9 0.17 -8.54 6.29 0.46 -0.73 -1.24

P/B

-8.9 -11.3 -11.8 20.1 8.8 15.4 7.6 10.8 9.0 7.5 6.5 6.5 5.1 4.2 5.8

P/CF

8.6 6.6 5.9 -23.1 32.7 19.4 29.7 13.9 20.6 30.1 -35.2 23.6 12.8 30.4 65.4

ROE %

-40.62 8.93 142.20 -296.21 50.58 55.11 64.10 17.96 33.65 44.09 25.75 30.07 22.67 17.69 29.99

ROA %

5.30 -1.22 -11.13 -10.18 10.68 11.46 15.21 2.09 7.95 11.23 6.32 8.09 8.32 5.13 8.18

ROCE %

-100.31 -53.46 65.25 -293.84 71.35 83.26 17.32 13.60 19.48 18.45 19.15 23.84 22.51 15.24 19.14

Current Ratio

0.9 0.9 0.9 1.0 1.3 1.3 1.7 1.4 1.6 1.7 1.5 1.7 1.7 2.3 2.1

DSO

19.4 24.7 31.0 36.4 35.5 30.9 39.2 31.0 27.3 27.6 24.5 30.4 28.4 44.5 41.6

DIO

91.7 102.3 149.9 155.9 93.0 76.6 92.3 97.7 89.1 88.9 76.2 77.7 64.7 81.2 77.1

DPO

37.6 36.7 46.8 65.1 53.2 39.9 36.6 30.5 33.5 32.9 37.0 39.0 27.4 29.8 29.9

Operating Cycle

111.2 127.0 180.8 192.3 128.5 107.5 131.5 128.7 116.4 116.4 100.7 108.1 93.1 125.7 118.7

Cash Conversion Cycle

73.6 90.3 134.1 127.2 75.3 67.6 94.9 98.1 82.9 83.5 63.7 69.1 65.7 95.9 88.8

All numbers in USD currency

Quarterly Financial Ratios The Scotts Miracle-Gro Company

2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

2.58 3.78 -1.21 - 2.33 2.77 -1.42 - 0.78 1.95 -1.17 -3.91 -8.01 4.98 0.44 10.06 4.05 5.57 - 0.07 3.65 4.53 -1.28 -1.04 3.63 -1.28 -1.44 -2.65 1.5 -1.44 -0.37 -0.57 2.57 -0.37 -1.09 -0.44 3.49 -1.09 - -0.38 2.18 2.05 -1.23 -0.24 1.99 -1.23 -1.06 -0.31 2.4 -1.06 -1.1 -0.66 1.53 -1.1 -1.21 -0.86 1.73 -1.21

EBITDA per Share

- - -0.61 - - - -0.55 - - - -0.44 -2.88 -10.2 6.99 0.89 14.5 5.97 7.61 - 11.1 5.66 6.35 -0.86 9.07 5.15 -0.86 -1.28 6.95 3.81 -1.28 -1.03 8.58 4.45 -1.03 -0.8 8.72 4 -0.95 - 5.77 3.53 3.8 -1.54 6 3.7 -1.54 -1.24 5.97 4.48 -1.23 -1.28 5.36 3.2 -1.28 -1.41 6.14 3.36 -1.43

ROE %

-238.08 -241.19 -228.99 -132.24 -99.82 22.95 165.29 3.24 -144.02 -282.60 -333.81 -231.08 -28.52 97.78 102.39 108.96 54.21 63.17 65.82 54.39 45.77 44.75 -2.85 -23.48 -56.88 -61.57 -82.19 -54.35 -18.04 -18.01 9.83 2.79 4.21 10.60 3.55 11.01 10.93 2.63 37.76 21.07 22.12 22.61 -14.16 -8.04 -8.02 -9.14 -3.01 -5.61 -9.54 -14.90 -17.51 -20.26 -23.13 -18.70 -21.44 -9.54 19.94 -15.92

ROA %

12.57 11.53 9.39 5.63 6.61 3.81 1.99 1.75 -3.31 -13.18 -10.92 -10.75 5.99 19.77 21.78 23.14 11.58 12.69 13.57 11.51 9.48 10.14 0.62 0.21 -2.69 -6.63 -7.03 -5.29 -1.70 1.12 2.86 1.42 1.67 3.74 2.34 3.57 3.60 1.28 9.28 5.98 6.18 6.81 -1.41 -1.16 -1.42 0.31 0.57 0.43 -0.50 -3.65 -3.80 -4.03 -4.70 -3.76 -3.99 -2.60 5.44 -3.41

ROCE %

-370.86 -381.92 -371.55 -233.04 -175.70 18.51 276.93 137.06 -5.19 -197.07 -307.25 -232.91 -15.64 145.81 151.10 229.57 237.11 251.00 174.10 164.07 146.01 141.13 80.37 56.20 89.31 105.76 81.59 101.48 74.70 58.72 78.61 82.25 79.72 73.66 75.73 137.31 119.95 120.46 119.08 95.35 103.72 109.16 48.13 57.41 44.43 43.19 52.51 49.06 50.65 43.88 40.40 36.96 50.42 56.52 52.82 61.36 34.37 -21.59

Current Ratio

0.9 0.9 0.9 0.9 1.0 0.9 0.9 0.9 1.0 1.0 1.0 1.0 1.1 1.2 1.2 1.3 1.3 1.3 - 1.3 1.3 1.3 1.2 1.3 1.3 1.2 1.1 1.1 1.1 1.1 1.2 1.3 1.3 1.2 1.2 1.4 1.4 1.2 - 1.3 1.3 1.3 1.3 1.4 1.4 1.3 1.4 1.6 1.6 1.4 1.3 1.4 1.4 1.3 1.3 1.4 1.4 1.3

DSO

52.7 32.5 42.7 - 52.4 34.8 65.8 - 71.5 40.1 52.9 12.9 64.0 36.3 50.6 16.8 43.7 12.1 - 48.7 29.0 22.0 52.0 41.0 16.2 44.5 59.7 47.5 17.9 13.2 67.2 47.9 15.3 12.8 66.6 42.3 21.9 42.4 - 38.3 14.3 16.0 110.2 45.0 16.7 72.5 87.8 43.5 14.6 75.9 116.8 75.3 21.6 74.2 112.0 73.2 21.3 -

DIO

74.5 88.7 215.6 - 76.8 92.2 264.2 - 104.3 121.0 311.3 52.0 155.0 112.0 182.5 33.8 85.5 44.4 - 27.1 59.5 81.9 206.1 28.6 85.9 236.2 214.4 30.8 88.0 251.9 268.5 26.9 85.3 336.3 289.0 25.1 86.4 170.3 - 23.6 50.8 76.9 260.7 23.5 70.3 314.5 272.7 19.9 61.1 353.8 277.2 24.1 70.6 339.9 273.2 23.5 72.3 -

DPO

37.2 37.2 81.2 - 40.6 35.7 77.8 - 40.5 35.7 85.6 13.5 41.2 42.3 92.1 17.4 44.1 24.0 - 17.0 37.4 38.5 76.7 11.3 32.0 80.1 67.7 9.6 27.8 80.4 91.6 10.1 29.1 107.5 93.5 8.8 30.2 57.6 - 11.5 24.7 29.5 100.9 11.8 27.2 110.0 108.0 8.4 24.2 117.6 88.2 8.9 22.5 106.0 97.1 9.1 25.7 -

Operating Cycle

127.3 121.2 258.3 - 129.2 127.0 330.0 - 175.8 161.2 364.1 64.9 219.0 148.3 233.1 50.6 129.2 56.4 - 75.8 88.5 103.9 258.1 69.6 102.1 280.7 274.0 78.3 105.9 265.1 335.7 74.8 100.6 349.1 355.6 67.4 108.3 212.7 - 61.9 65.1 93.0 370.9 68.5 87.0 387.1 360.5 63.4 75.7 429.7 394.0 99.4 92.2 414.1 385.2 96.7 93.6 -

Cash Conversion Cycle

90.0 84.0 177.1 - 88.6 91.3 252.2 - 135.3 125.5 278.5 51.4 177.8 106.0 140.9 33.2 85.1 32.4 - 58.7 51.1 65.3 181.3 58.3 70.2 200.6 206.3 68.7 78.1 184.6 244.1 64.7 71.5 241.6 262.1 58.6 78.0 155.2 - 50.4 40.4 63.5 270.0 56.7 59.8 277.0 252.5 54.9 51.5 312.1 305.8 90.5 69.8 308.1 288.1 87.6 67.9 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company The Scotts Miracle-Gro Company, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Agricultural inputs industry

Issuer Price % 24h Market Cap Country
Bioceres Crop Solutions Corp. Bioceres Crop Solutions Corp.
BIOX
$ 1.59 0.63 % $ 435 M argentinaArgentina
Акрон Акрон
AKRN
- - - russiaRussia
ФосАгро ФосАгро
PHOR
- - - russiaRussia
China Green Agriculture China Green Agriculture
CGA
- 0.51 % $ 27.6 M chinaChina
ICL Group Ltd ICL Group Ltd
ICL
$ 5.07 0.3 % $ 7.83 B israelIsrael
Marrone Bio Innovations Marrone Bio Innovations
MBII
- -5.9 % $ 180 M usaUSA
CF Industries Holdings CF Industries Holdings
CF
$ 78.88 0.28 % $ 14.2 B usaUSA
FMC Corporation FMC Corporation
FMC
$ 13.92 1.9 % $ 1.74 B usaUSA
Corteva Corteva
CTVA
$ 65.85 -0.29 % $ 45.7 B usaUSA
Arcadia Biosciences Arcadia Biosciences
RKDA
$ 3.64 -1.62 % $ 4.5 M usaUSA
American Vanguard Corporation American Vanguard Corporation
AVD
$ 4.29 -3.27 % $ 120 M usaUSA
Yield10 Bioscience Yield10 Bioscience
YTEN
- 15.32 % $ 46.6 M usaUSA
Intrepid Potash Intrepid Potash
IPI
$ 27.3 -0.84 % $ 352 M usaUSA
The Mosaic Company The Mosaic Company
MOS
$ 26.23 4.13 % $ 8.39 B usaUSA
Nutrien Ltd. Nutrien Ltd.
NTR
$ 62.61 2.64 % $ 34.8 B canadaCanada
Origin Agritech Limited Origin Agritech Limited
SEED
$ 1.44 -3.99 % $ 8.09 M chinaChina
CVR Partners, LP CVR Partners, LP
UAN
$ 95.2 0.37 % $ 1.01 B usaUSA